Benefits
Blood sugar and insulin resistance markers alongside metformin
In a 12-week placebo-controlled trial of 80 adults with type 2 diabetes already taking metformin, neem leaf and twig extract (125 to 500 mg twice daily) lowered fasting and post-meal glucose, HbA1c and HOMA-IR more than placebo, with larger changes at higher doses. Natreon Inc. supplied the test and placebo capsules. A second trial by the same group reported similar results.
Inflammation markers (IL-6 and hsCRP)
In the metformin add-on trial, IL-6 and hsCRP fell more with neem extract than with placebo, most clearly at 500 mg twice daily. TNF-α fell from baseline in the neem groups but did not differ from placebo. All human data so far come from small trials run by one research group.
Endothelial function and oxidative stress markers
At 250 and 500 mg twice daily, a pulse-wave measure of endothelial function improved and blood glutathione rose versus placebo; malondialdehyde fell only at 500 mg. The 125 mg dose did not change endothelial function versus placebo, and platelet aggregation and blood lipids did not change at any dose.
Dental plaque and gum scores with neem mouthwash (not swallowed)
In small randomized trials, neem mouthrinses lowered plaque and gingival index scores, and a neem toothpaste trial reported a significant difference from a control toothpaste; trials with a chlorhexidine arm found broadly similar score changes. A systematic review of three trials judged their methods flawed and concluded that clinical evidence for neem mouthrinses is lacking.
Mechanism of action
Limonoid and flavonoid constituents
Reviews list more than 140 compounds in neem, including limonoids such as azadirachtin, nimbolide and gedunin plus flavonoids and phenolic acids. The leaf and twig extract used in human trials was characterized by flavonoid glycosides (quercetin and rutin derivatives) and myo-inositol monophosphate. Neem's insecticidal and antifeedant activity underlies its agricultural use.
Inflammatory signaling (NF-κB, Nrf2 and MAPK)
Laboratory and animal studies report that neem limonoids act on NF-κB, PI3K/Akt/mTOR, Nrf2 and MAPK signaling. In people, one placebo-controlled trial found lower IL-6 and hsCRP with neem extract, while TNF-α did not differ from placebo, so the human picture is narrower than the laboratory findings.
Glucose handling and insulin resistance
Neem extracts lowered blood glucose in diabetic rodent models. In human trials, the leaf and twig extract lowered HOMA-IR, an index of insulin resistance, alongside fasting glucose and HbA1c; the exact mechanism in people has not been established.
Oxidative stress markers
In the metformin add-on trial, blood glutathione rose at 250 and 500 mg twice daily and malondialdehyde fell at 500 mg compared with placebo, while nitric oxide did not differ between groups. Reviews describe Nrf2 pathway activity for neem limonoids in laboratory work.
Clinical trials
Randomized, single-center, double-blind, placebo-controlled trial in India (CTRI/2018/12/016666). Four arms: placebo or aqueous neem leaf and twig extract 125, 250 or 500 mg twice daily for 12 weeks, on top of metformin 1500 to 2500 mg/day. Natreon Inc. (New Brunswick, NJ, USA) supplied the test and placebo capsules, biomarker kits and literature; the authors declared no competing interests. (Pingali et al. 2020, Diabetes Metab Syndr Obes)
80 adults with type 2 diabetes on metformin randomized (20 per group); 78 completed.
All three doses lowered fasting and post-meal glucose, HbA1c and HOMA-IR versus placebo, most at 500 mg (HbA1c 7.78% to 6.26%). IL-6 and hsCRP fell versus placebo; TNF-α did not differ from placebo. Endothelial function and glutathione improved at 250 and 500 mg. Platelet aggregation and lipid profile did not change. Two participants had mild stomach upset that subsided with symptomatic treatment; no low blood sugar was reported.
Randomized, placebo-controlled trial (CTRI/2019/03/018034) of aqueous neem leaf and twig extract 125, 250 or 500 mg twice daily or placebo for 12 weeks, by the same research group as the metformin add-on trial. The abstract does not name the product supplier or funding. (Pingali et al. 2021, J Med Food)
Subjects with metabolic syndrome, 20 per group.
The abstract reports dose-related improvements in fasting and post-meal glucose, insulin resistance and HbA1c, and improvements in endothelial function and most inflammation and oxidative stress markers. It gives no numeric between-group results, and lipid profile and platelet aggregation were measured but their results are not stated.
Double-blind, randomized, controlled trial with three groups rinsing with 15 mL neem mouthrinse, chlorhexidine or saline twice daily, assessed weekly over 21 days. (Chatterjee et al. 2011, J Indian Soc Periodontol)
45 subjects with plaque-induced gingivitis, 15 per group.
Gingival, bleeding and plaque index scores fell in both the neem and chlorhexidine groups compared with saline, with no difference between neem and chlorhexidine. The abstract reports no numeric values or P values.
Randomized, blinded controlled trial of 0.2% chlorhexidine, 2% neem or 0.5% tea mouthwash, assessed over 3 weeks. (Balappanavar et al. 2013, Indian J Dent Res)
30 healthy volunteers aged 18 to 25, 10 per group.
Plaque and gingival scores fell in all groups. The tea mouthwash had the largest anti-plaque effect; neem showed a larger gingival effect than chlorhexidine (P < 0.05). The authors concluded that 0.5% tea was more effective than either neem or chlorhexidine.
Randomized, double-blind crossover trial of 2% neem versus 0.2% chlorhexidine mouthwash with a 1-week washout between phases. The abstract gives 40 participants but also describes 20 allocated, so the analyzed number is unclear. (Jalaluddin et al. 2017, J Contemp Dent Pract)
Adults aged 18 to 35.
Plaque scores fell slightly with both mouthwashes, with no significant difference between them. Gingival index scores fell within both groups.
Randomized, double-blind trial of a neem-containing toothpaste versus a control toothpaste; duration and control product not stated in the abstract. (Abhishek et al. 2015, J Contemp Dent Pract)
30 dental students (22 women, 8 men).
Plaque index and gingival index differed significantly between the neem and control toothpaste groups; the abstract gives no values or direction, and the authors concluded that neem toothpaste can be used as an adjunct for maintaining oral hygiene.
Systematic review searching PubMed, Cochrane CENTRAL and EMBASE up to February 2015 plus hand searching; 206 records screened, 3 randomized trials included; no meta-analysis because of marked heterogeneity. (Dhingra et al. 2017, Int J Dent Hyg)
3 randomized trials of neem mouthrinse.
All three trials found neem mouthrinse about as effective as chlorhexidine as an adjunct to toothbrushing, but reporting and methods were generally flawed with unclear risk of bias, and the authors concluded that evidence for clinical use of neem mouthrinses is lacking.